FFR Technologies

This channel includes news and new technology innovations for fractional flow reserve (FFR) wires, catheters and systems used to measure blood flow across a coronary lesion to determine if a stent is needed or if the plaque stenosis can be treated medically. The section includes iFR, instantaneous wave-free ratio, systems used in the cath lab and noninvasive FFR technologies including computed tomography-FFR. This is also referred to as CT-FFR or FFR-CT.

In June 2019, Medis received clearance from the U.S. Food and Drug Administration for its QAngio XA 3D technology (QFR). The FFR-angio technology can show the FFR readings in a 3-D image and overlaid on a fluoro image.

In June 2019, Medis received clearance from the U.S. Food and Drug Administration for its QAngio XA 3D technology (QFR). The FFR-angio technology can show the FFR readings in a 3-D image and overlaid on a fluoro image. 

Feature | FFR Technologies | August 05, 2019 | Dave Fornell and Greg Freiherr

New technologies have been developed that may replace the traditional pressure wires and adenosine to assess the...

An example of FFR-CT imaging from Beaumont Hospital in Royal Oak, Mich. The left image shows a 3D generated image of the coronary tree from a CT scan evaluated with computational fluid dynamics to determine the FFR numbers. It shows a severe restriction of the left main artery which requires a stent to revacularize. The image on the right is a comparison with the invasive angiogram from the cath lab prior to stenting.

An example of FFR-CT imaging from Beaumont Hospital in Royal Oak, Mich. The left image shows a 3D generated image of the coronary tree from a CT scan evaluated with computational fluid dynamics to determine the FFR numbers. It shows a severe restriction of the left main artery which requires a stent to revacularize. The image on the right is a comparison with the invasive angiogram from the cath lab prior to stenting. 

Feature | CT Angiography (CTA) | July 24, 2019 | Greg Freiherr

One of the big trends in cardiac computed tomography (CT) imaging has been the introduction of noninvasive ...

Novel Index Accurately Predicts PCI Success Post-Procedure Compared to Established Measurement Metrics
News | Cath Lab | June 19, 2019

June 19, 2019 — Results from a comprehensive analysis demonstrate the effectiveness of measuring a non-hyperemic...

First Prospective Registry Confirms FFR Impacts CAD Treatment Plans
News | FFR Technologies | June 17, 2019

June 17, 2019 – A prospective, multicenter, multinational study examines how...

Medis QAngio XA 3D Receives FDA 510k Clearance
Technology | Angiography | June 04, 2019

June 4, 2019 — Medis Medical Imaging Systems B.V. has received clearance from the U.S. Food and Drug Administration...

HeartFlow Planner Changes Treatment Strategy for Coronary Heart Disease Patients
News | CT Angiography (CTA) | May 28, 2019

May 28, 2019 — New data demonstrated that use of the investigational HeartFlow Planner, a real-time, non-invasive...

Philips Launches IntraSight Interventional Applications Platform
Technology | Intravascular Imaging | May 20, 2019

May 20, 2019 — Philips announced the launch of the new IntraSight...

SyncVision iFR Co-registration from Philips Healthcare maps pressure readings onto angiogram. Results from an international study presented at ACC 2019 indicates pressure readings obtained using iFR (instantaneous wave-free ratio, also referred to as instant wave-free ratio or instant flow reserve) in coronary arteries may localize stenoses that remain after interventions. FFR in the cath lab.

SyncVision iFR Co-registration from Philips Healthcare maps pressure readings onto angiogram. Results from an international study presented at ACC 2019 indicates pressure readings obtained using iFR (instantaneous wave-free ratio, also referred to as instant wave-free ratio or instant flow reserve) in coronary arteries may localize stenoses that remain after interventions.

Feature | ACC | March 27, 2019 | Greg Freiherr, Contributing Editor
The fingerprints of value-added medicine were all over products and works-in-progress on the exhibit floor of the...
At #ACC.19, Siemens unveiled a version of its go.Top platform optimized for cardiovascular imaging. The newly packaged scanner can generate the data needed to do CT-based FFR (fractional flow reserve).

At #ACC.19, Siemens unveiled a version of its go.Top platform optimized for cardiovascular imaging. The newly packaged scanner can generate the data needed to do CT-based FFR (fractional flow reserve). Photo by Greg Freiherr

Feature | Cardiac Imaging | March 22, 2019 | By Greg Freiherr

Reflecting a trend toward the increased use of ...

The opening late-breaking trial at ACC 2019 is the Apple Heart Study, a large-scale, app-based study to identify atrial fibrillation using a smartwatch. Earlier, smaller trials showed this approach might be used in a population health application to proactively identify AFib patients earlier.

Feature | ACC | March 19, 2019

The American College of Cardiology (ACC) released a list of the...

HeartFlow Analysis Successfully Stratifies Heart Disease Patients at One Year
News | FFR Technologies | March 19, 2019

March 19, 2019 — Late-breaking results confirm the HeartFlow FFRct (...

Abbott's Resting Full-cycle Ratio (RFR) intravascular diagnostic test is a newer type of fractional flow reserve (FFR) physiologic assessment. RFR is used to help identify significant narrowings of coronary arteries to determine the need for a stent or if a patient can be treated medically. Abbott FFR.

Abbott's Resting Full-cycle Ratio (RFR) intravascular diagnostic test is a newer type of fractional flow reserve (FFR) physiologic assessment. RFR is used to help identify significant narrowings of coronary arteries to determine the need for a stent or if a patient can be treated medically. 

Technology | FFR Technologies | March 06, 2019

March 5, 2019 –  The U.S. Food and Drug Administration (FDA) cleared Abbott's Resting Full-cycle Ratio (RFR)...

CathWorks FFRangio System Receives U.S. FDA Clearance
Technology | FFR Technologies | December 21, 2018

 

December 21, 2018 — CathWorks announced that its FFRangio System received U.S. Food  and Drug...

Overlay Init